Table 2:
Comparison of salivary TAC (Total Antioxidant Capacity) levels between patients with RAS in active lesion phase and control group.
–
Patients
(active lesion phase)
Control
P
value*
Salivary TAC concentrations
(Mmol / L)
0.26±0.16
0.24±0.13
0.641
*
Unpaired t-test.